Cleaner nanotechnology and hazard reduction of manufactured nanoparticles

被引:127
作者
Reijnders, L [1 ]
机构
[1] Univ Amsterdam, ECDO, IBED, NL-1018 WV Amsterdam, Netherlands
关键词
nanotechnology; nanoparticles; ultrafine particles; exposure; hazard; biodegradation;
D O I
10.1016/j.jclepro.2005.03.018
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Though it has been claimed that nanotechnology has great potential for cleaner technology, caution is required as to application of nanoparticles (< 100 nm). Studies relevant to human exposure have shown that nanoparticles can be hazardous. Manufactured nanoparticles may also have ecotoxicological effects after discharge into water. There is a case to limit human exposure to nanoparticles originating in production. As traditional 'end-of-pipe' technology has limited effectiveness in capturing nanoparticles, source reduction is important for the limitation of exposure during production. With regard to products, it seems important to distinguish between applications that are inherently dispersive and applications that are not inherently dispersive. In case of dispersive applications, alternatives and 'built in' hazard reduction merit consideration. Hazard reduction may be possible by e.g. limiting biopersistence, arranging for low toxicity of degradation products or surface modification. When nanoparticles are applied in a way that is not inherently dispersive, controlling the size of particles that originate due to cleaning, wear, tear and corrosion is important. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:124 / 133
页数:10
相关论文
共 113 条
  • [1] Zinc is the toxic factor in the lung response to an atmospheric particulate sample
    Adamson, IYR
    Prieditis, H
    Hedgecock, C
    Vincent, R
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 166 (02) : 111 - 119
  • [2] ADELMANN P, 1994, ILSI MONOGR, P405
  • [3] Drug delivery systems: Entering the mainstream
    Allen, TM
    Cullis, PR
    [J]. SCIENCE, 2004, 303 (5665) : 1818 - 1822
  • [4] Inhaled particles and lung cancer, part B: Paradigms and risk assessment
    Borm, PJA
    Schins, RPF
    Albrecht, C
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (01) : 3 - 14
  • [5] The hemolytic properties of chemically modified cyclodextrins
    Bost, M
    Laine, V
    Pilard, F
    Gadelle, A
    Defaye, J
    Perly, B
    [J]. JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, 1997, 29 (01) : 57 - 63
  • [6] BOSWELL C, 2002, CHEM MARKET REP 1111, P6
  • [7] Size-dependent proinflammatory effects of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines
    Brown, DM
    Wilson, MR
    MacNee, W
    Stone, V
    Donaldson, K
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 175 (03) : 191 - 199
  • [8] Nanotechnology: A little knowledge ...
    Brumfiel, G
    [J]. NATURE, 2003, 424 (6946) : 246 - 248
  • [9] Incorporation of biodegradable nanoparticles into human airway epithelium cells - in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases
    Brzoska, M
    Langer, K
    Coester, C
    Loitsch, S
    Wagner, TOF
    Mallinckrodt, CV
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 318 (02) : 562 - 570
  • [10] Augmentation of pulmonary reactions to quartz inhalation by trace amounts of iron-containing particles
    Castranova, V
    Vallyathan, V
    Ramsey, DM
    McLaurin, JL
    Pack, D
    Leonard, S
    Barger, MW
    Ma, JYC
    Dalal, NS
    Teass, A
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 : 1319 - 1324